Abstract
The pyruvate dehydrogenase complex (PDHc) is an intramitochondrial multienzyme system, which plays a key role in aerobic glucose metabolism by catalysing the oxidative decarboxylation of pyruvate to acetyl-CoA. Genetic defects in the PDHc lead to lactic acidemia and neurological abnormalities. In the majority of the cases, the defect appears to reside in the E1α subunit, the first catalytic component of the complex. The report is on a 6-year-old Portuguese boy with mild neurological involvement and low PDHc activity with absence of E1α on immunoblotting analysis. Molecular studies showed a novel and “de novo” mutation in the PDHA1 gene, R253G. Treatment with arginine aspartate showed complete clinical and biochemical recovery. We hypothesise that arginine aspartate acts as a chemical or pharmacological chaperone, and suggest amino acid supplementation as a possible therapy in PDHA1 mutations with mild phenotypes. Conclusion: our results encourage the use of amino acid supplementation to overcome the metabolic/biochemical changes induced by PDHA1 gene specific mutations associated with mild PDHc phenotypes.
Similar content being viewed by others
Abbreviations
- PDHc:
-
pyruvate dehydrogenase complex
- TPP:
-
thiamine pyrophosphate
- E1:
-
pyruvate dehydrogenase
- PDHA:
-
subunit α of E1
- PDHB:
-
subunit β of E1
- DLAT:
-
dihydrolipoamide acetyltransferase or E2
- DLD:
-
dihydrolipoamide dehydrogenase or E3
- PDHX:
-
E3 binding protein
- PDP:
-
pyruvate dehydrogenase phosphatase
- PDK:
-
pyruvate dehydrogenase kinase
References
Amaral MD (2006) Therapy through chaperones; sense or antisense? Cystic fibrosis as a model disease. J Inher Metab Dis 29:477–487
Arakawa T, Tsumoto K (2003) The effects of arginine on refolding of aggregated proteins: not facilitate refolding, but suppress aggregation. Biochem Biophys Res Commun 304:148–152
Arora D, Khanna N (1996) Methods for increasing the yield of properly folded recombinant human gamma interferon from inclusion bodies. J Biotechnol 52:127–133
Baynes BM, Wang DIC, Trout BL (2005) Role of arginine in the stabilization of proteins against aggregation. Biochem 44:4919–4925
Boyum A (1968) Isolation of mononuclear cells and granulocytes from human blood. J Clin Lab Invest 97:77–89
Brown RM, Head RA, Boubriak II, Leonard JV, Thomas NH, Brown GK (2004) Mutations in the gene for the E1beta subunit: a novel cause of pyruvate dehydrogenase deficiency. Hum Genet 115:123–127
Clot JP, Benelli C, de Gallé B, Postel-Vinay MC, Durand D, Debuquois B (1988) Effects of growth hormone on Pyruvate Dehydrogenase activity in intact rat liver and in isolated hepatocytes: comparison with insulin. Metabolism 37:1101–1106
Fujii T, Garcia Alvarez MB, Sheu KF, Kranz-Eble PJ, De Vivo DC (1996) Pyruvate Dehydrogenase Deficiency: the relation of the E1 alpha mutation ton the E1 beta subunit deficiency. Pediatr Neurol 14:328–334
Fujii T, Van Coster RN, Old SE, Medori R, Winter S, Gubits RM, Matthews PM, Brown RM, Brown GK, Dahl H-HM, De Vivo DC (1994) Pyruvate dehydrogenase deficiency: molecular basis for intrafamilial heterogeneity. Ann Neurol 36:83–89
Head RA, Brown RM, Zolkipli Z, Shahdadpuri R, King MD, Clayton PT, Brown GK (2005) Clinical and genetic spectrum of pyruvate dehydrogenase deficiency: dihydrolipoamide acetyltransferase (E2) deficiency. Ann Neurol 58:234–241
Jacobia SJ, Korotchkina LG, Patel MS (2001) Differential effects of two mutations at Arginine-234 in the a subunit of human pyruvate dehydrogenase. Arch Biochem Biophys 395:121–128
Laemmli UK (1970) Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227:680–685
Lissens W, De Meirleir L, Seneca S, Benelli C, Marsac C, Poll-The BT, Briones P, Ruitenbeek W, van Diggelen O, Chaigne D, Ramaekers V, Liebaers I (1996) Mutation analysis of the Pyruvate Dehydrogenase E1α gene in eight patients with a Pyruvate Dehydrogenase Complex deficiency. Hum Mut 7:46–51
Lissens W, De Meirleir L, Seneca S, Liebaers I, Brown GK, Brown RM, Ito M, Naito E, Kuroda Y, Kerr DS, Wexler ID, Patel MS, Robinson BH, Seyda A (2000) Mutations in the X-linked Pyruvate Dehydrogenase (E1) α sub-unit (PDHA-1) in patients with a Pyruvate Dehydrogenase Complex deficiency. Hum Mut 15:209–219
Lissens W, Vreken P, Barth PG, Wijburg FA, Ruitenbeek W, Wanders RJA, Seneca S, Liebaers I, De Meirleir L (1999) Cerebral palsy and pyruvate dehydrogenase deficiency: identification of two new mutations in the E1a gene. Eur J Pediatr 158:853–857
Liu TC, Kim H, Arizmendi C, Kitano A, Patel MS (1993) Identification of two missense mutations in a dihydrolipoamide dehydrogenase deficient patient. Proc Natl Acad Sci USA 90:5186–5190
Maj MC, Cameron JM, Robinson BH (2006) Pyruvate dehydrogenase phosphatase deficiency: orphan disease or an under-diagnosed condition? Mol Cell Endocrinol 249:1–9
Maj MC, MacKay N, Levandovskiy V, Addis J, Baumgartner ER, Baumgartner MR, Robinson BH, Cameron JM (2005) Pyruvate dehydrogenase phosphatase deficiency: identification of the first mutation in two brothers and restoration of activity by protein complementation. J Clin Endocrinol Metab 90:4101–4107
Marsac C, Benelli C, Desguerre I, Diry M, Fouque F, De Meirleir L, Ponsot G, Seneca S, Poggi F, Saudubray JM (1997) Biochemical and genetics studies of four patients with pyruvate dehydrogenase E1a deficiency. Hum Genet 99:785–792
Matsuda J, Ito M, Naito E, Yokota Y, Kuroda Y (1995) DNA diagnosis of Pyruvate Dehydrogenase deficiency in female patients with congenital lactic acidaemia. J Inher Metab Dis 18:534–546
Okajima K, Warman LM, Byrne LC, Kerr DS (2006) Somatic mosaicism in a male with an exon skipping in PDHA1 of the pyruvate dehydrogenase complex results in a milder phenotype. Mol Genet Metab 87:162–168
Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T (1989) Detection of polymorfisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86:2766–2770
Otero LJ, Brown RM, Brown GK (1998) Arginine 302 mutations in the Pyruvate Dehydrogenase E1α subunit gene: identification of further patients and in vitro demonstration of pathogenicity. Hum Mut 12:114–121
Robinson BH, MacKay N, Petrova-Benedict R, Ozalp I, Coskun T Stacpoole PW (1990) Defects in the E2 lipoyl transacetilase and the X-lipoyl containing component of the pyruvate dehydrogenase complex in patients with lactic academia. J Clin Invest 85:1821–1824
Robinson BH (2001) Lactic acidemia: disorders of pyruvate carboxylase, and pyruvate dehydrogenase. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill Inc, New York, pp 2275–2295
Sato S, Ward CL, Krouse ME, Wine JJ, Kopito RR (1996) Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J Biol Chem 271:635–638
Seals JR, Jarett L (1980) Activation of pyruvate dehydrogenase by direct addition of insulin to an isolated plasma membrane/mitochondria mixture evidence for generation of insulin’s second messenger in a subcellular system. Proc Natl Acad Sci USA 77:77–81
Suenaga M, Ohmae H, Tsuji S, Itoh T, Nishimura O (1998) Renaturation of recombinant human neutrophin-3 from inclusion bodies using a suppressor agent of aggregation. Biotechnol Appl Biochem 28:119–124
Towbin H, Staehlint, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350–4354
Tsumoto K, Umetsu M, Kumagai I, Ejima D, Philo JS, Arakawa T (2004) Role of arginine in protein refolding, solubilization, and purification. Biotechnol Prog 20:1301–1308
Zhang XM, Wang XT, Yue H, Leung SW, Thibodeau PH, Thomas PJ, Guggino SE (2003) Organic solutes rescue the functional defect in delta F508cystic fibrosis transmembrane conductance regulator. J Biol Chem 278:51232–51242
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
João Silva, M., Pinheiro, A., Eusébio, F. et al. Pyruvate dehydrogenase deficiency: identification of a novel mutation in the PDHA1 gene which responds to amino acid supplementation. Eur J Pediatr 168, 17–22 (2009). https://doi.org/10.1007/s00431-008-0700-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-008-0700-7